Model
Edge
Seres Therapeutics
0001760671
Filing Type
4
Filing Date
6/22/2023
Updated
6/23/23, 11:25 AM
Copy Ref
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership